These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36628952)

  • 21. Influence of Pathogenic and Metabolic Genes on the Pharmacogenetics of Mood Disorders in Alzheimer's Disease.
    Cacabelos R; Carril JC; Corzo L; Fernández-Novoa L; Pego R; Cacabelos N; Cacabelos P; Alcaraz M; Tellado I; Naidoo V
    Pharmaceuticals (Basel); 2021 Apr; 14(4):. PubMed ID: 33920985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic Editing and Pharmacogenetics in Current And Future Therapy Of Neurocognitive Disorders.
    Prendecki M; Kowalska M; Toton E; Kozubski W
    Curr Alzheimer Res; 2020; 17(3):238-258. PubMed ID: 32321403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenomics and therapeutic prospects in Alzheimer's disease.
    Cacabelos R
    Expert Opin Pharmacother; 2005 Oct; 6(12):1967-87. PubMed ID: 16197352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacogenetics of treating pediatric anxiety and depression.
    Ramsey LB; Bishop JR; Strawn JR
    Pharmacogenomics; 2019 Aug; 20(12):867-870. PubMed ID: 31453769
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacogenetic relevant polymorphisms of CYP2C9, CYP2C19, CYP2D6, and CYP3A5 in Bhutanese population.
    Dorji PW; Wangchuk S; Boonprasert K; Tarasuk M; Na-Bangchang K
    Drug Metab Pers Ther; 2019 Dec; 34(4):. PubMed ID: 32004143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam.
    Veiga MI; Asimus S; Ferreira PE; Martins JP; Cavaco I; Ribeiro V; Hai TN; Petzold MG; Björkman A; Ashton M; Gil JP
    Eur J Clin Pharmacol; 2009 Apr; 65(4):355-63. PubMed ID: 18979093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinically relevant pharmacogenetic markers in Tatars and Balkars.
    Abdullaev SP; Mirzaev KB; Burashnikova IS; Shikaleva AA; Kachanova AA; Abdullaev SP; Akmalova KA; Sozaeva ZA; Grishina EA; Sozaeva MS; Rytkin EI; Sychev DA
    Mol Biol Rep; 2020 May; 47(5):3377-3387. PubMed ID: 32303955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interethnic Variability in CYP2D6, CYP2C9, and CYP2C19 Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans: RIBEF-CEIBA Consortium Report on Population Pharmacogenomics.
    Naranjo MG; Rodrigues-Soares F; Peñas-Lledó EM; Tarazona-Santos E; Fariñas H; Rodeiro I; Terán E; Grazina M; Moya GE; López-López M; Sarmiento AP; Calzadilla LR; Ramírez-Roa R; Ortiz-López R; Estévez-Carrizo FE; Sosa-Macías M; Barrantes R; LLerena A;
    OMICS; 2018 Sep; 22(9):575-588. PubMed ID: 30183544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenomics of Alzheimer's and Parkinson's diseases.
    Cacabelos R
    Neurosci Lett; 2020 May; 726():133807. PubMed ID: 30236877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drinking Ethanol Has Few Acute Effects on CYP2C9, CYP2C19, NAT2, and P-Glycoprotein Activities but Somewhat Inhibits CYP1A2, CYP2D6, and Intestinal CYP3A: So What?
    Gazzaz M; Kinzig M; Schaeffeler E; Jübner M; Hsin CH; Li X; Taubert M; Trueck C; Iltgen-Breburda J; Kraus D; Queckenberg C; Stoffel M; Schwab M; Sörgel F; Fuhr U
    Clin Pharmacol Ther; 2018 Dec; 104(6):1249-1259. PubMed ID: 29633238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacogenomics in drug induced liver injury.
    Andrade RJ; Agúndez JA; Lucena MI; Martínez C; Cueto R; García-Martín E
    Curr Drug Metab; 2009 Nov; 10(9):956-70. PubMed ID: 20214588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacogenetics in American Indian populations: analysis of CYP2D6, CYP3A4, CYP3A5, and CYP2C9 in the Confederated Salish and Kootenai Tribes.
    Fohner A; Muzquiz LI; Austin MA; Gaedigk A; Gordon A; Thornton T; Rieder MJ; Pershouse MA; Putnam EA; Howlett K; Beatty P; Thummel KE; Woodahl EL
    Pharmacogenet Genomics; 2013 Aug; 23(8):403-14. PubMed ID: 23778323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ABCB1, ABCG2 and CYP2D6 polymorphism effects on disposition and response to long-acting risperidone.
    Ganoci L; Trkulja V; Živković M; Božina T; Šagud M; Lovrić M; Božina N
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110042. PubMed ID: 32682874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of Metabolic, Transporter, and Pathogenic Genes on Pharmacogenetics and DNA Methylation in Neurological Disorders.
    Martínez-Iglesias O; Naidoo V; Carrera I; Carril JC; Cacabelos N; Cacabelos R
    Biology (Basel); 2023 Aug; 12(9):. PubMed ID: 37759556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of 107 genomic DNA reference materials for CYP2D6, CYP2C19, CYP2C9, VKORC1, and UGT1A1: a GeT-RM and Association for Molecular Pathology collaborative project.
    Pratt VM; Zehnbauer B; Wilson JA; Baak R; Babic N; Bettinotti M; Buller A; Butz K; Campbell M; Civalier C; El-Badry A; Farkas DH; Lyon E; Mandal S; McKinney J; Muralidharan K; Noll L; Sander T; Shabbeer J; Smith C; Telatar M; Toji L; Vairavan A; Vance C; Weck KE; Wu AH; Yeo KT; Zeller M; Kalman L
    J Mol Diagn; 2010 Nov; 12(6):835-46. PubMed ID: 20889555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Traditional Herbal Formulas to as Treatments for Musculoskeletal Disorders: Their Inhibitory Effects on the Activities of Human Microsomal Cytochrome P450s and UDP-glucuronosyltransferases.
    Jin SE; Seo CS; Shin HK; Ha H
    Pharmacogn Mag; 2016; 12(48):241-252. PubMed ID: 27867264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fetal pharmacogenomics: A promising addition to complex neonatal care.
    Raymond M; Critchlow E; Rice SM; Wodoslawsky S; Berger SI; Hegde M; Empey PE; Al-Kouatly HB
    Mol Genet Metab; 2022; 137(1-2):140-145. PubMed ID: 36029725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans.
    Dong C; Wong ML; Licinio J
    Mol Psychiatry; 2009 Dec; 14(12):1105-18. PubMed ID: 19844206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics.
    Hoffman JM; Haidar CE; Wilkinson MR; Crews KR; Baker DK; Kornegay NM; Yang W; Pui CH; Reiss UM; Gaur AH; Howard SC; Evans WE; Broeckel U; Relling MV
    Am J Med Genet C Semin Med Genet; 2014 Mar; 166C(1):45-55. PubMed ID: 24619595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of genetic variants of CYP2D6, CYP2C9, CYP2C19 and CYP3A4 on antiepileptic drug metabolism in pediatric patients with refractory epilepsy.
    López-García MA; Feria-Romero IA; Serrano H; Rayo-Mares D; Fagiolino P; Vázquez M; Escamilla-Núñez C; Grijalva I; Escalante-Santiago D; Orozco-Suarez S
    Pharmacol Rep; 2017 Jun; 69(3):504-511. PubMed ID: 28343093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.